Blesa, Javier

Oxidative stress and Parkinson’s disease

Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 878

The basal ganglia in Parkinson's disease: Current concepts and unexplained observations

Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., Mena-Segovia, J., Rodríguez, M., & Olanow, C. W. (2009) · Annals of Neurology

Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments

Cited by 359

Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?

Blesa, J., Foffani, G., Dehay, B., Bezard, E., & Obeso, J. A. (2022) · Nature Reviews Neuroscience

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 232

Identification of neurodegenerative factors using translatome–regulatory network analysis

Brichta, L., Shin, W., Jackson-Lewis, V., Blesa, J., Yap, E.-L., Walker, Z., Zhang, J., Roussarie, J.-P., Alvarez, M. J., Califano, A., et al. (2015) · Nature Neuroscience

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 118

Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (PROTAC)

Salinas-Rebolledo, C., Blesa, J., Valenzuela-Nieto, G., Schwefel, D., del Rey, N. L. G., Méndez-Ruette, M., Burkhalter, J., Bátiz, L. F., Jara, R., Obeso, J. A., et al. (2024) · eLife

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 3

Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)

Salinas-Rebolledo, C., Blesa, J., Valenzuela-Nieto, G., Schwefel, D., López-González del Rey, N., Méndez-Ruette, M., Burkhalter, J., Carrazana, E., Díaz-Tejeda, F., Arias Catalán, I., et al. (2025) · eLife

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 3